Status:
COMPLETED
Lipoprotein-associated Phospholipase A2 in Patients With Type 2 Diabetes
Lead Sponsor:
Nanjing First Hospital, Nanjing Medical University
Conditions:
Type2 Diabetes
Eligibility:
All Genders
Brief Summary
Lipoprotein-associated phospholipase A2 (LP-PLA2) is a good marker of cardiovascular risk and inflammation. This study aims at the characteristic and clinical significance of LP-PLA2 test in patients ...
Detailed Description
The investigators recorded clinical factors, serum levels of glucose, HbA1c, lipids and LP-PLA2 in patients with T2D who visited in the Department of Endocrinology at the Nanjing First Hospital from J...
Eligibility Criteria
Inclusion
- Patients with T2D and the diagnostic criteria of T2D is according to the World Health Organization in 1999.
Exclusion
- Patients use systemic steroidal anti-inflammatory drugs.
- Patients are pregnant.
- Patients with an acute infection.
Key Trial Info
Start Date :
January 30 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2017
Estimated Enrollment :
1713 Patients enrolled
Trial Details
Trial ID
NCT03362112
Start Date
January 30 2015
End Date
June 1 2017
Last Update
April 14 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.